BIO-TECHNE Corp SEC filings TECH
BIO-TECHNE Corp has 1,001 filings in SEC EDGAR's recent list, going back to Feb 14, 2008. Its latest annual report, Form 10-K, was filed on Aug 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 9, 2020 | — |
| S-8 | Employee stock plan registration | Nov 7, 2018 | — |
| S-8 | Employee stock plan registration | Oct 26, 2017 | — |
| S-8 | Employee stock plan registration | Oct 30, 2015 | — |
| S-8 | Employee stock plan registration | Nov 4, 2014 | — |
| S-8 | Employee stock plan registration | Nov 12, 2010 | — |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECH (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- MN
- Headquarters
- Minneapolis, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/ (until Oct 28, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.